Cargando…

Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli

In this research, metabolic engineering was employed to synthesize the artificial major ampullate spidroin 2 (MaSp2) in the engineered Escherichia coli. An iterative seamless splicing strategy was used to assemble the MaSp2 gene, which could reach 10000 base pairs, and more than 100 kDa protein was...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Hao, Parveen, Shafaq, Ding, Ding, Xu, Haijun, Tan, Tianwei, Liu, Luo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595792/
https://www.ncbi.nlm.nih.gov/pubmed/28900203
http://dx.doi.org/10.1038/s41598-017-11845-2
_version_ 1783263417485754368
author Cao, Hao
Parveen, Shafaq
Ding, Ding
Xu, Haijun
Tan, Tianwei
Liu, Luo
author_facet Cao, Hao
Parveen, Shafaq
Ding, Ding
Xu, Haijun
Tan, Tianwei
Liu, Luo
author_sort Cao, Hao
collection PubMed
description In this research, metabolic engineering was employed to synthesize the artificial major ampullate spidroin 2 (MaSp2) in the engineered Escherichia coli. An iterative seamless splicing strategy was used to assemble the MaSp2 gene, which could reach 10000 base pairs, and more than 100 kDa protein was expected. However, only 55 kDa recombinant MaSp2 was obtained. Because MaSp2 is rich in alanine and glycine residues, Glycyl/alanyl-tRNA pool and extra amino acids adding were adopted in order to supplement alanine and glycine in the protein translation process. With the supplementary alanine and glycine (0.05 wt%) in the medium, MaSp2 constructed in pET28a(+) and Gly/Ala-tRNA constructed in pET22b(+) were co-expressed in Escherichia coli BL21 (DE3). As results, the artificial MaSp2 with 110 kDa molecular weight was obtained in the present work. This work demonstrates a successful example of applying metabolic engineering approaches and provided a potential way with the enhanced Glycyl/alanyl-tRNA pool to achieve the expression of high molecular weight protein with the repeated motifs in the engineered Escherichia coli.
format Online
Article
Text
id pubmed-5595792
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55957922017-09-14 Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli Cao, Hao Parveen, Shafaq Ding, Ding Xu, Haijun Tan, Tianwei Liu, Luo Sci Rep Article In this research, metabolic engineering was employed to synthesize the artificial major ampullate spidroin 2 (MaSp2) in the engineered Escherichia coli. An iterative seamless splicing strategy was used to assemble the MaSp2 gene, which could reach 10000 base pairs, and more than 100 kDa protein was expected. However, only 55 kDa recombinant MaSp2 was obtained. Because MaSp2 is rich in alanine and glycine residues, Glycyl/alanyl-tRNA pool and extra amino acids adding were adopted in order to supplement alanine and glycine in the protein translation process. With the supplementary alanine and glycine (0.05 wt%) in the medium, MaSp2 constructed in pET28a(+) and Gly/Ala-tRNA constructed in pET22b(+) were co-expressed in Escherichia coli BL21 (DE3). As results, the artificial MaSp2 with 110 kDa molecular weight was obtained in the present work. This work demonstrates a successful example of applying metabolic engineering approaches and provided a potential way with the enhanced Glycyl/alanyl-tRNA pool to achieve the expression of high molecular weight protein with the repeated motifs in the engineered Escherichia coli. Nature Publishing Group UK 2017-09-12 /pmc/articles/PMC5595792/ /pubmed/28900203 http://dx.doi.org/10.1038/s41598-017-11845-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Cao, Hao
Parveen, Shafaq
Ding, Ding
Xu, Haijun
Tan, Tianwei
Liu, Luo
Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli
title Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli
title_full Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli
title_fullStr Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli
title_full_unstemmed Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli
title_short Metabolic engineering for recombinant major ampullate spidroin 2 (MaSp2) synthesis in Escherichia coli
title_sort metabolic engineering for recombinant major ampullate spidroin 2 (masp2) synthesis in escherichia coli
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595792/
https://www.ncbi.nlm.nih.gov/pubmed/28900203
http://dx.doi.org/10.1038/s41598-017-11845-2
work_keys_str_mv AT caohao metabolicengineeringforrecombinantmajorampullatespidroin2masp2synthesisinescherichiacoli
AT parveenshafaq metabolicengineeringforrecombinantmajorampullatespidroin2masp2synthesisinescherichiacoli
AT dingding metabolicengineeringforrecombinantmajorampullatespidroin2masp2synthesisinescherichiacoli
AT xuhaijun metabolicengineeringforrecombinantmajorampullatespidroin2masp2synthesisinescherichiacoli
AT tantianwei metabolicengineeringforrecombinantmajorampullatespidroin2masp2synthesisinescherichiacoli
AT liuluo metabolicengineeringforrecombinantmajorampullatespidroin2masp2synthesisinescherichiacoli